Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 21;14:587747. doi: 10.3389/fncel.2020.587747

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Zhuang, Chen, Cai, Wang, Yang, Li, Yang and Zhu.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

PTGS2 inhibition and CDK5 inhibition reversed the effect of FOXQ1 inhibition on inflammation. Comparisons of TNF-α (A), IL-1β (B), and IL-6 (C) levels among blank, NC, Si-FOXQ1, Si-PTGS2, Si-FOXQ1andSi-PTGS2, Si-CDK5, and Si-FOXQ1andSi-CDK5 cells in primary neuron AD model. Comparisons of TNF-α (D), IL-1β (E), and IL-6 (F) levels among blank, NC, Si-FOXQ1, Si-PTGS2, Si-FOXQ1andSi-PTGS2, Si-CDK5, and Si-FOXQ1andSi-CDK5 cells in PC-12 cellular AD model. FOXQ1, forkhead box Q1; PTGS2, prostaglandin-endoperoxide synthase 2; CDK5, cyclin-dependent kinase 5; TNF-α, tumor necrosis factor-α; IL-1β, interleukin 1β; IL-6, interleukin 6; NC, negative control; AD, Alzheimer disease. *p < 0.05, **p < 0.01, ***p < 0.001.